Non-radioactive HPRT Assay

Including active human HPRT enzyme

PRECICE® HPRT Assay kit provides the first non radioactive protocol for measurement of HPRT activity in a convenient 96-well plate format.

Hypoxanthine-guanine phosphoribosyltransferase (HPRT, EC 2.4.2.8), a key enzyme of the purine salvage pathway, is encoded by highly variable HPRT1 gene. More than 300 mutations in HPRT1 gene associated with genetic disorders in humans have been described leading to partial or complete deficiency of HPRT enzyme. Complete HPRT deficiency is a rare human genetic disorder, also known as Lesch-Nyhan syndrom. In some cases, gout, more frequent purine disorder, can also be secondary to HPRT deficiency (Ceballos-Picot I. et al 2010). High variability of HPRT1 gene complicates genetic testing. Currently, HPRT enzyme functions are tested in red blood cell lysates in a chromatographic assay using radiolabeled 14C-hypoxanthine (Cartier P. et al, 1968).

Principle:
HPRT activity is measured by tracking the production of IMP, which is oxidized by recombinant IMP dehydrogenase. This process leads to the formation of NADH2, continuously monitored spectrophotometrically at 340 nm for real-time measurements.

HPRT enzyme Molecular Structure

PRECICE® HPRT Assay Kit

#K0709-01-2
#REF SIZE PRICE
#K0709-01-2 24 analyses (8 samples in triplicate) with HPRT enzyme 330.00 € Inquiry

Updated on October 2nd, 2024.

Kit is provided in stable lyophilized form and shipped without dry ice

Download HPRT assay Protocol (User manual)

Download Material Safety Data Sheet (MSDS)

Wide Detection Range

Detect HPRT activity from 6.75 nmol/hour/ml to 340 nmol/hour/ml, enabling the characterization of complete and partial deficiencies.

Accurate

Measurement imprecisions: 1.5% (within-run), 5% (between-day), and 6.5% (total).

Fast

Simultaneous analysis of up to 15 samples in triplicate in 2 hours.

Convenient

No sample preparation nor prior inactivation of cellular 5'-nucleotidase required. Cell lysates are directly used for continuous monitoring of HPRT activity.

Validated

Specific activities of HPRT in lysates of erythrocytes, PBMC and cultured cells measured by PRECICE® HPRT Assay kit are comparable to those obtained previously by radiochemical procedure.

HPRT Activity

Cells PRECICE® HPRT Assay Kit Published Data References
RBC specimen 1 (n=4) 76.94±2.5 nmol/h/mg of Hgb 80–120 nmol/h/mg of hemoglobin 4
RBC specimen 2 (n=12) 78.03±5.52 nmol/h/mg of Hgb
RBC specimen 3 (n=4) 88.7±3.41 nmol/h/mg of Hgb
PBMC specimen 1 (n=4) 159.91±3.60 nmol/h/mg of protein
19.7±0.6 nmol/h/106 PBMC
343±18 nmol/h/mg of protein
10.2–18.0 nmol/h/106 PBMC
4
PBMC specimen 2 (n=4) 152.30±4.94 nmol/h/mg of protein
21.3±0.42 nmol/h/106 PBMC
5
Human Dermal Fibroblasts (Invitrogen) 70.91±2.67 nmol/h/mg of protein 81–127 nmol/h/mg of protein 6
W20-17 cells (ATCC) 91.95±4.49 nmol/h/mg of protein
HPRT Assay Kit Calibration Graph
Calibration curve of IMPDH-based PRECICE® HPRT Assay

The rate of the increase in absorbance at 340nm per hour as a function of the concentration of human recombinant HPRT enzyme (NovoCIB, ref. E-Nov-9). The changes in absorbance corresponding to 3 different control hemolysates diluted in complete reaction mixture to final hemoglobin concentration 1mg/ml (n=4) are shown by filled squares, filled triangles and filled circles. The insert shows a linear correlation observed in whole range of 21ng/ml up to 1.5µg/ml of recombinant HPRT; the units are the same.

Scientific Articles citing PRECICE® HPRT Assay kit from NOVOCIB:
  1. Ablation of Atp5if1 impairs metabolic reprogramming and proliferation of T lymphocytes and compromises mouse survival
    I. Romero-Carraminana, S. Dominguez-Zorita, P.B. Esparza-Molto, J. M. Cuezva (2024) iScience 27, 109863
  2. Electron transport chain inhibition increases cellular dependence on purine transport and salvage
    Z. Wu, D. Bezwada, F. Cai, J. Garcia-Bermudez, M. Ni, R.J. DeBerardinis, Cell Metab. 2024 Jun 7:S1550-4131(24)00190-6
  3. Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing (2023)
    G. Jang , H. Rim Shin, H.-S. Do , J. Kweon , S. Hwang , S. Kim, S. Hee Heo, Y. Kim, B. Lee Molecular Therapy - Nucleic Acids ; 31: 586-595.
  4. Rescuing compounds for Lesch-Nyhan disease identified using stem cell-based phenotypic screening (2020)
    V. Ruillier, J. Tournois, C. Boissart, M. Lasbareilles, G. Mahé, L. Chatrousse, M. Cailleret, M. Peschanski, A. Benchoua JCI Insight 5(4): e132094.
  5. Hypoxanthine-guanine phosphoribosyltransferase and inosine 5'-monophosphate dehydrogenase activities in three mammalian species: aquatic (Mirounga angustirostris), semi-aquatic (Lontra longicaudis annectens) and terrestrial (2015)
    M. Barjau Pérez-Milicua, T. Zenteno-Savín, D.E. Crocker, J.P. Gallo-Reynoso Front Physiol.; 6: 212.
  6. Prolonged fasting increases purine recycling in post-weaned northern elephant seals
    José Guadalupe Soñanez-Organis, José Pablo Vázquez-Medina, Tania Zenteno-Savín, Andres Aguilar, Daniel E. Crocker, Rudy M. Ortiz J Exp Biol (2012) 215 (9): 1448-1455.